We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Recovery After Gastric Cancer Surgery

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by Hoon Hur, Ajou University School of Medicine.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01642953
First Posted: July 17, 2012
Last Update Posted: July 20, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
JW Pharmaceutical
Information provided by (Responsible Party):
Hoon Hur, Ajou University School of Medicine
  Purpose

Study preparation

  • To progress this prospective study, the investigators analyzed the retrospective data of 426 patients who had been managed with conventional critical pathway after gastric cancer surgery during last 1 year.
  • Through this retrospective analysis, we decided the inclusion criteria which showed significantly the lower complication rate and shorter hospital stay.

Method for Prospective study

  • Patients who enroll in this prospective study are administered and are supplied a liquid diet one day before surgery without bowel preparation.
  • After gastric cancer surgery, they start sips of water on postoperative first day, and they are discharged once they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.

Condition Intervention Phase
Fasting Malignant Neoplasm of Stomach Dietary Supplement: Early recovery Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Clinical Study for Early Recovery After Gastric Cancer Surgery

Resource links provided by NLM:


Further study details as provided by Hoon Hur, Ajou University School of Medicine:

Primary Outcome Measures:
  • Drop rate from critical pathway [ Time Frame: 4 days ]
    It is defined as the proportion of dropped patients from 4 days critical pathway


Secondary Outcome Measures:
  • Postoperative pain [ Time Frame: 7 days ]
    It is defined as the change of pain scale after surgery

  • Postoperative complication [ Time Frame: 30 days ]
    It is defined the complications after surgery

  • Postoperative mortality [ Time Frame: 30 days ]
    It will defined as the death case during 30 days after surgery

  • Recovery after surgery [ Time Frame: 7 days ]
    It is defined as the time to first flatus and recovery of bowel activity after surgery


Estimated Enrollment: 109
Study Start Date: July 2012
Estimated Study Completion Date: August 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Early recovery

Patients who enroll in this arm are supplied a liquid diet one day before surgery without bowel preparation.

After gastric cancer surgery, they start sips of water on postoperative first day, and they are discharged once they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.

Dietary Supplement: Early recovery
The patients are started on sips of water on the first postoperative day. If they are tolerable, a liquid diet is started on the second postoperative day, and a soft diet on a third postoperative day for them. We have a plan to discharge the patients on the fourth postoperative day if they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.

Detailed Description:

Enrollment of patients

  • Before the patients are enrolled in this study, they give us informed consents.
  • A liquid diet is supplied beginning from the morning of the day prior to operation to the midnight.

Operation and postoperative management

  • All procedures are approached by laparoscopic surgery, and partial gastrectomy with lymph node dissection are performed.
  • The patients who are considered to be difficult to progress early oral feeding in surgical field are excluded from the study.
  • Nasogastric tube is not applied to patients.
  • Postoperative pain is managed by non-opioid pain killer.
  • The patients are started on sips of water on the first postoperative day.
  • If they are tolerable, a liquid diet is started on the second postoperative day, and a soft diet on a third postoperative day for them.
  • We have a plan to discharge the patients on the fourth postoperative day if they exhibit at least three times soft diet without specific complaint and had normal clinical status and physical examination.

Evaluation of patients

- The patients are followed up to 30 days after discharge from hospital, and we check whether they are tolerable without any compliant and are readmitted.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who are diagnosed with gastric adenocarcinoma
  • 65 years old and blew
  • Patients are expected to be undergone distal subtotal gastrectomy
  • No complication by gastric cancer
  • No synchronous metastatic lesions
  • Laparoscopic or robotic surgery
  • Informed consent

Exclusion Criteria:

  • Previous gastrectomy history
  • Combined surgery due to synchronous malignancy
  • Patients with major organ dysfunction
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01642953


Contacts
Contact: Hoon Hur, Prof. +82-31-219-5200 hhcmc75@naver.com

Locations
Korea, Republic of
Ajou University Hospital Recruiting
Suwon, Korea, Republic of, 443-721
Contact: Hoon Hur, prof.    +82-31-219-5200    hhcmc75@naver.com   
Contact: Sang-Uk Han, prof.    +82-31-219-5200    hansu@ajou.ac.kr   
Sub-Investigator: Sang-Uk Han, Professor         
Sub-Investigator: Cheul Soo Byun, Instructor         
Sponsors and Collaborators
Ajou University School of Medicine
JW Pharmaceutical
Investigators
Principal Investigator: Hoon Hur, Prof. Ajou University School of Medicine
  More Information

Additional Information:
Responsible Party: Hoon Hur, Assistant Professor, Ajou University School of Medicine
ClinicalTrials.gov Identifier: NCT01642953     History of Changes
Other Study ID Numbers: AJIRB-MED-MDB-12-002
First Submitted: July 14, 2012
First Posted: July 17, 2012
Last Update Posted: July 20, 2012
Last Verified: July 2012

Keywords provided by Hoon Hur, Ajou University School of Medicine:
Gastric cancer surgery
Early oral feeding
Fast track surgery

Additional relevant MeSH terms:
Stomach Neoplasms
Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases


To Top